Comparison of Fasia Iliac Compartment Block and 4in1 Block

June 25, 2025 updated by: Savas Altinsoy, Diskapi Yildirim Beyazit Education and Research Hospital

Comparison of Perioperative Analgesic Effectiveness of Patients Who Had Fasia Iliac Compartment Block and 4in1 Block Applied in Total Knee Prosthesis Surgery

Patients who will undergo elective total knee arthroplasty surgery under spinal anesthesia will be included in the study according to the postoperative analgesia method applied: Group Control, Group FICB and Group 4in1. Peripheral nerve block will be performed with 30 ml %0.25 bupivacaine for Group FICB and Group 4 in 1 patients. Peripheral nerve block will not be performed on Group Control patients. Patient-controlled analgesia will be given to all three groups in the postoperative period. PCA is a pain palliation method routinely used in all patients postoperatively. NRS score, PCA tramadol consumption, PCA demand, need for additional analgesia, patient satisfaction, nausea and vomiting will be monitored 24 hours postoperatively. The aim of this study is to compare the perioperative analgesic effectiveness of patients who underwent fascia iliaca compartment block and 4 in 1 block in total knee arthroplasty surgery, with each other and with the control group.

Study Overview

Status

Completed

Conditions

Detailed Description

Total knee arthroplasty is a surgical procedure performed mostly on patients with osteoarthritis who have failed traditional conservative treatment. Increasing knee osteoarthritis due to reasons such as life expectancy and body mass index causes this surgical procedure to be performed more frequently. The knee joint which is innervated by the femoral, obturator, sciatic nerves and their branches has a complicated innervation and the pain following total knee arthrplasty is quite severe. It is aimed to provide effective analgesia by blocking these nerves or terminal branches with various peripheral nerve blockade methods under USG guidance. In recent years, interest in studies aiming to block these nerves with a single injection has been increasing. 4 in 1 block is a new technique applied from a single injection point to block the saphenous, obturator, sciatic and vastus medialis nerves that innervate the knee joint. Fascia iliaca compartment block is a reliable technique applied from a single injection point to block the femoral, lateral femoral cutaneous and obturator nerves behind the fascia iliaca.

Patients who will undergo elective total knee arthroplasty surgery under spinal anesthesia will be included in the study according to the postoperative analgesia method applied: Group Control, Group FICB and Group 4in1. Peripheral nerve block will be performed with 30 ml %0.25 bupivacaine for Group FICB and Group 4 in 1 patients. Peripheral nerve block will not be performed on Group Control patients. Patient-controlled analgesia will be given to all three groups in the postoperative period. PCA is a pain palliation method routinely used in all patients postoperatively. NRS score, PCA tramadol consumption, PCA demand, need for additional analgesia, patient satisfaction, nausea and vomiting will be monitored 24 hours postoperatively. The aim of this study is to compare the perioperative analgesic effectiveness of patients who underwent fascia iliaca compartment block and 4 in 1 block in total knee arthroplasty surgery, with each other and with the control group.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey, 06450
        • Department of Anesthesiology and Reanimation, University of Health Sciences, Diskapi Yıldırım Beyazit Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Study Population

Patients who undergone total knee arthroplasty

Description

Inclusion Criteria:

  • With informed consent
  • Elective total knee arthroplasty with spinal anesthesia
  • Oriented and cooperative
  • ASA Classification I-II-III
  • 18-85 years old

Exclusion Criteria:

  • Anticoagulant medication
  • Coagulopathy
  • Infection at the site of peripheral nerve block application
  • Allergy to local anesthetics
  • Pregnant or suspected pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Group Control
Peripheral nerve block will not be performed on Group Control patients.
Peripheral nerve block will not be performed on Group Control patients.
Other: Group FICB
FICB will be performed with 30 ml %0.25 bupivacaine for Group FICB patients.
FICB is applied to the patients after spinal anesthesia.
Other: Group 4 IN 1
4 in 1 block will be performed with 30 ml %0.25 bupivacaine for Group 4 IN 1 patients.
4 in 1 block is applied to the patients after spinal anesthesia.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total tramadol consumption in 24 hours (mg)
Time Frame: 24 hours postoperatively
Total tramadol consumption used in the first 24 hours postoperatively
24 hours postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain on the Numeric Rating Scale (NRS)
Time Frame: 0 hours postoperatively
NRS range was from 0-10 with being no pain and 10 the worst pain possible.
0 hours postoperatively
Pain on the Numeric Rating Scale (NRS)
Time Frame: 1 hours postoperatively
NRS range was from 0-10 with being no pain and 10 the worst pain possible.
1 hours postoperatively
Pain on the Numeric Rating Scale (NRS)
Time Frame: 4 hours postoperatively
NRS range was from 0-10 with being no pain and 10 the worst pain possible.
4 hours postoperatively
Pain on the Numeric Rating Scale (NRS)
Time Frame: 8 hours postoperatively
NRS range was from 0-10 with being no pain and 10 the worst pain possible.
8 hours postoperatively
Pain on the Numeric Rating Scale (NRS)
Time Frame: 12 hours postoperatively
NRS range was from 0-10 with being no pain and 10 the worst pain possible.
12 hours postoperatively
Pain on the Numeric Rating Scale (NRS)
Time Frame: 24 hours postoperatively
NRS range was from 0-10 with being no pain and 10 the worst pain possible.
24 hours postoperatively
Rescue Analgesic
Time Frame: 24 hours postoperatively
Consumption of rescue analgesic used after 24 hours postoperatively.
24 hours postoperatively
Patient satisfaction
Time Frame: 24 hours postoperatively
The patient is satisfied or dissatisfied
24 hours postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 30, 2024

Primary Completion (Actual)

July 1, 2024

Study Completion (Actual)

July 8, 2024

Study Registration Dates

First Submitted

May 24, 2024

First Submitted That Met QC Criteria

May 24, 2024

First Posted (Actual)

May 30, 2024

Study Record Updates

Last Update Posted (Actual)

June 29, 2025

Last Update Submitted That Met QC Criteria

June 25, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Postoperative

Clinical Trials on FICB

Subscribe